Related Experiment Video
Updated: Aug 30, 2025

10:11
Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
Published on: September 27, 2014
36.4K
Identifying Paucisymptomatic or Asymptomatic and Unrecognized Ebola Virus Disease Among Close Contacts Based on
Dehkontee Gayedyu-Dennis1, Mosoka P Fallah1,2, Clara Drew3
1Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia.
The Journal of Infectious Diseases
|September 1, 2022
Summary
Screening algorithms using rapid antigen tests and exposure assessments can identify asymptomatic Ebola virus disease (EVD) in contacts. These strategies offer high sensitivity for detecting unrecognized EVD, balancing utility and trade-offs.
Area of Science:
- Infectious Diseases
- Epidemiology
- Public Health
Background:
- Limited evidence exists for screening algorithms to detect asymptomatic or paucisymptomatic Ebola virus (EBOV) infection and unrecognized Ebola virus disease (EVD).
- Effective identification strategies are crucial for controlling EVD transmission.
Purpose of the Study:
- To evaluate screening algorithms using rapid diagnostic testing (RDT) and exposure assessments for identifying contacts with asymptomatic or unrecognized EVD.
- To determine the utility and trade-offs of sequential screening strategies.
Main Methods:
- A cohort study classified contact-participants based on serostatus and postexposure symptoms into uninfected, paucisymptomatic/asymptomatic infection, or unrecognized EVD groups.
- Exposure risk was categorized as low, intermediate, or high.
- Hypothetical scenarios evaluated the World Health Organization (WHO) case definition with or without RDT and exposure assessments.
Main Results:
- Of 1909 contacts, 115 (6%) had paucisymptomatic/asymptomatic EBOV infection, and 107 (6%) had unrecognized EVD.
- High-risk exposures significantly increased the odds of unrecognized EVD (aOR, 3.5).
- Sensitivity for identifying unrecognized EVD was high with RDT (96%) and intermediate- to high-risk exposures (97%), with low false-positive rates for RDT (2%).
Conclusions:
- Sequential screening algorithms incorporating RDT and exposure risk assessments are valuable for identifying contacts with unrecognized EVD.
- These strategies demonstrate utility and trade-offs in detecting asymptomatic or unrecognized EVD cases.
- The findings support enhanced surveillance and contact tracing protocols for EVD.

